Carin A. Uyl‐de Groot
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 15
- Oncology top 2%
- Hematology top 2%
- Multiple Myeloma Research and Treatments 22
- Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life 63
- Economic and Financial Impacts of Cancer 35
- Pharmaceutical Economics and Policy 13
- Genetics top 5%
-
- Lymphoma Diagnosis and Treatment 21
-
- Lung Cancer Treatments and Mutations 17
- Lung Cancer Diagnosis and Treatment 13
- Co-authors
- Ken RedekopPieter SonneveldM FrankenHedwig M. BlommesteinMartijn GrootMichel van AgthovenPeter C. HuijgensBob Löwenberg
- Journals
- JAMA (1 paper)Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Carin A. Uyl‐de Groot
202 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 147
- Otorhinolaryngology 237
- Oncology 1.5k
- Hematology 512
- Economics and Econometrics 889
- Genetics 316
Countries citing papers authored by Carin A. Uyl‐de Groot
This map shows the geographic impact of Carin A. Uyl‐de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin A. Uyl‐de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin A. Uyl‐de Groot more than expected).
Fields of papers citing papers by Carin A. Uyl‐de Groot
This network shows the impact of papers produced by Carin A. Uyl‐de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin A. Uyl‐de Groot. The network helps show where Carin A. Uyl‐de Groot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carin A. Uyl‐de Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 18 | |
| 5 | 2024 | 17 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 43 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 27 | |
| 13 | 2021 | 20 | |
| 14 | 2020 | 26 | |
| 15 | 2020 | 26 | |
| 16 | 2020 | 25 | |
| 17 | 2007 | 12 | |
| 18 | 2006 | 108 | |
| 19 | Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma. | 2004 | 23 |
| 20 | 2001 | 22 |
About Carin A. Uyl‐de Groot
Carin A. Uyl‐de Groot is a scholar working on Otorhinolaryngology, Hematology and Oncology, having authored 217 papers that have together received 3.7k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (63 papers), Economic and Financial Impacts of Cancer (35 papers), Multiple Myeloma Research and Treatments (22 papers), Lymphoma Diagnosis and Treatment (21 papers), Lung Cancer Treatments and Mutations (17 papers), Head and Neck Cancer Studies (15 papers), Pharmaceutical Economics and Policy (13 papers) and Lung Cancer Diagnosis and Treatment (13 papers). The work is most often cited by research in Otorhinolaryngology (237 citations), Oncology (1.5k citations) and Hematology (512 citations). Carin A. Uyl‐de Groot has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Ken Redekop, Pieter Sonneveld, M Franken, Hedwig M. Blommestein, Martijn Groot, Michel van Agthoven, Peter C. Huijgens, Bob Löwenberg, Matthijs Versteegh and Elly Stolk. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.